Research Article
Prostaglandin D2 in Inflammatory Arthritis and Its Relation with Synovial Fluid Dendritic Cells
Table 1
Demographic and clinical characteristics of patients.
| | Diagnosis | Age (years) | Sex (years) | Disease duration | Treatment |
| | RA | 83 | F | 18 | DMARDs + NSAIDs + vitD + fish oil | | RA | 53 | F | 3 | DMARDs + NSAIDs + fish oil | | RA | 82 | F | 30 | DMARDs + vitD + fish oil | | RA | 48 | F | 22 | DMARDs + NSAIDs + fish oil | | RA | 61 | F | 13 | Tocilizumab + fish oil | | RA | 57 | F | 27 | DMARDs + Adalimumab + fish oil | | RA | 60 | F | 38 | DMARDs + vitD + fish oil | | RA | 62 | F | 2 | NSAIDs | | RA | 82 | F | 11 | DMARDs + fish oil | | RA | 50 | F | 1 | DMARDs + vitD + fish oil | | RA | 66 | F | 10 | DMARDs + vitD | | RA | 67 | F | 29 | DMARDs + vitD | | RNP+ polyarthritis | 55 | F | 3 | DMARDs + NSAIDs + vitD + fish oil | | B27+ Pauci-arthritis | 35 | F | 18 | DMARDs + vitD + fish oil | | Psoriatic arthritis | 58 | F | 6 | DMARDs + vitD + fish oil | | Psoriatic arthritis | 55 | F | 2 | Fish oil | | B27+ spondyloarthritis | 62 | M | 41 | DMARDs + NSAIDs + fish oil | | Juvenile onset-monoarthritis | 34 | F | 26 | NSAIDs | | Crohn’s arthritis | 46 | F | 30 | DMARDs + vitD | | Crohn’s arthritis | 70 | F | 13 | DMARDs + NSAIDs + vitD + fish oil |
|
|
RA: rheumatoid arthritis; DMARDs: disease-modifying anti-inflammatory drugs; NSAIDs: nonsteroidal anti-inflammatory drugs.
|
